← Leaderboards
Sathyanarayana N Murthy
University Of Mississippi
$3,354,822
Attributed
$3,354,822
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500K · FY2006–22$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
FDA$2,193,499 · 2
NIH$1,161,323 · 6
By mechanism
U01$2,193,499 · 2
R21$568,640 · 2
R03$275,498 · 2
P20$172,436 · 1
R15$144,749 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Biological Availability”
- David Heimbrook · Leidos Biomedical Research, Inc.$382,069,903
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$225,482,153
- Christopher McKay · Battelle Memorial Institute$156,659,640
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- David R. Weir · University Of Michigan At Ann Arbor$124,409,862
- Jeffrey P Krischer · University Of South Florida$108,549,354
Research focus
Biological AvailabilitySkinEnhancersRattusPenetrationAdverse EffectsPharmaceutical PreparationsDrug Delivery SystemsPropertyInfectionMediatingOralChildhoodIn VitroAbsorptionLeadDoseReportingRoutePolymersPhysiologicalSiteMolecular WeightCompliance Behavior
Grant awards (20)
Impact of Formulation Composition on the Structure and Performance Attributes of Topical Products$175,000
U01 · FY2022 · FD · contact PI
Impact of Formulation Composition on the Structure and Performance Attributes of Topical Products$146,377
U01 · FY2020 · FD · contact PI
Impact of Formulation Composition on the Structure and Performance Attributes of Topical Products$102,122
U01 · FY2020 · FD · contact PI
Impact of Formulation Composition on the Structure and Performance Attributes of Topical Products$250,000
U01 · FY2019 · FD · contact PI
Novel Topical Formulation for the Management of Vulvodynia$187,633
R21 · FY2019 · HD · contact PI
Topical Products and Critical Quality Attributes$250,000
U01 · FY2018 · FD · contact PI
Impact of Formulation Composition on the Structure and Performance Attributes of Topical Products$250,000
U01 · FY2018 · FD · contact PI
Topical Products and Critical Quality Attributes$250,000
U01 · FY2017 · FD · contact PI
Topical Products and Critical Quality Attributes$250,000
U01 · FY2016 · FD · contact PI
Topical Products and Critical Quality Attributes$250,000
U01 · FY2015 · FD · contact PI
Topical Products and Critical Quality Attributes$20,000
U01 · FY2015 · FD · contact PI
Topical Products and Critical Quality Attributes$250,000
U01 · FY2014 · FD · contact PI
A NOVEL METHOD TO TREAT CHRONIC PAIN$212,771
R21 · FY2013 · NS · contact PI
A NOVEL METHOD TO TREAT CHRONIC PAIN$168,236
R21 · FY2012 · NS · contact PI
TRANSDERMAL DELIVERY OF IRON$66,533
R03 · FY2011 · HD · contact PI
P7: VEHICLES TO IMPROVE NOSE TO BRAIN BIOAVAILABILITY OF DRUGS$172,436
P20 · FY2010 · RR · contact PI
TRANSDERMAL DELIVERY OF IRON$69,305
R03 · FY2010 · HD · contact PI
Electropulsation mediated drug therapy for Onychomycosis$69,830
R03 · FY2009 · EB · contact PI
Electropulsation mediated drug therapy for Onychomycosis$69,830
R03 · FY2008 · EB · contact PI
Electroporation and transcutaneous extraction of drugs$144,749
R15 · FY2006 · AR · contact PI